Literature DB >> 25038853

Emphysema progression is visually detectable in low-dose CT in continuous but not in former smokers.

Mathilde Marie Winkler Wille1, Laura H Thomsen, Asger Dirksen, Jens Petersen, Jesper Holst Pedersen, Saher B Shaker.   

Abstract

OBJECTIVES: To evaluate interobserver agreement and time-trend in chest CT assessment of emphysema, airways, and interstitial abnormalities in a lung cancer screening cohort.
METHODS: Visual assessment of baseline and fifth-year examination of 1990 participants was performed independently by two observers. Results were standardised by means of an electronic score sheet; kappa and time-trend analyses were performed.
RESULTS: Interobserver agreement was substantial in early emphysema diagnosis; highly significant (p < 0.001) time-trends in both emphysema presence and grading were found (higher prevalence and grade of emphysema in late CT examinations). Significant progression in emphysema was seen in continuous smokers, but not in former smokers. Agreement on centrilobular emphysema subtype was substantial; agreement on paraseptal subtype, moderate. Agreement on panlobular and mixed subtypes was only fair. Agreement was fair regarding airway analysis. Interstitial abnormalities were infrequent in the cohort, and agreement on these was fair to moderate. A highly significant time-trend was found regarding interstitial abnormalities, which were more frequent in late examinations.
CONCLUSIONS: Visual scoring of chest CT is able to characterise the presence, pattern, and progression of early emphysema. Continuous smokers progress; former smokers do not. KEY POINTS: • Substantial interobserver consistency in determining early-stage emphysema in low-dose CT. • Longitudinal analyses show clear time-trends for emphysema presence and grading. • For continuous smokers, progression of emphysema was seen in all lung zones. • For former smokers, progression of emphysema was undetectable by visual assessment. • Onset and progression of interstitial abnormalities are visually detectable.

Entities:  

Mesh:

Year:  2014        PMID: 25038853     DOI: 10.1007/s00330-014-3294-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  21 in total

1.  Visual quantitation and observer variation of signs of small airways disease at inspiratory and expiratory CT.

Authors:  C S Ng; S R Desai; M B Rubens; S P Padley; A U Wells; D M Hansell
Journal:  J Thorac Imaging       Date:  1999-10       Impact factor: 3.000

2.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis.

Authors:  David A Lynch; J David Godwin; Sharon Safrin; Karen M Starko; Phil Hormel; Kevin K Brown; Ganesh Raghu; Talmadge E King; Williamson Z Bradford; David A Schwartz; W Richard Webb
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

3.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

4.  A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.

Authors:  R Graham Barr; Eugene A Berkowitz; Francesca Bigazzi; Frederick Bode; Jessica Bon; Russell P Bowler; Caroline Chiles; James D Crapo; Gerard J Criner; Jeffrey L Curtis; Chandra Dass; Asger Dirksen; Mark T Dransfield; Goutham Edula; Leif Erikkson; Adam Friedlander; Maya Galperin-Aizenberg; Warren B Gefter; David S Gierada; Philippe A Grenier; Jonathan Goldin; MeiLan K Han; Nicola A Hanania; Nadia N Hansel; Francine L Jacobson; Hans-Ulrich Kauczor; Vuokko L Kinnula; David A Lipson; David A Lynch; William MacNee; Barry J Make; A James Mamary; Howard Mann; Nathaniel Marchetti; Mario Mascalchi; Geoffrey McLennan; James R Murphy; David Naidich; Hrudaya Nath; John D Newell; Massimo Pistolesi; Elizabeth A Regan; John J Reilly; Robert Sandhaus; Joyce D Schroeder; Frank Sciurba; Saher Shaker; Amir Sharafkhaneh; Edwin K Silverman; Robert M Steiner; Charlton Strange; Nicola Sverzellati; Joseph H Tashjian; Edwin J R van Beek; Lacey Washington; George R Washko; Gloria Westney; Susan A Wood; Prescott G Woodruff
Journal:  COPD       Date:  2012-03-19       Impact factor: 2.409

5.  Analysis of FEV1 decline in relatively healthy heavy smokers: implications of expressing changes in FEV1 in relative terms.

Authors:  Laura H Thomsen; Asger Dirksen; Saher B Shaker; Lene T Skovgaard; Magnus Dahlbäck; Jesper H Pedersen
Journal:  COPD       Date:  2013-10-10       Impact factor: 2.409

6.  Automated 3D ιnterstitial lung disease εxtent quantification: performance evaluation and correlation to PFTs.

Authors:  Alexandra Kazantzi; Lena Costaridou; Spyros Skiadopoulos; Panayiotis Korfiatis; Anna Karahaliou; Dimitris Daoussis; Andreas Andonopoulos; Christina Kalogeropoulou
Journal:  J Digit Imaging       Date:  2014-06       Impact factor: 4.056

Review 7.  Computed tomography of diffuse lung disease: functional correlates.

Authors:  D M Hansell
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

8.  The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.

Authors:  Jesper H Pedersen; Haseem Ashraf; Asger Dirksen; Karen Bach; Hanne Hansen; Phillip Toennesen; Hanne Thorsen; John Brodersen; Birgit Guldhammer Skov; Martin Døssing; Jann Mortensen; Klaus Richter; Paul Clementsen; Niels Seersholm
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

9.  Airflow limitation and airway dimensions in chronic obstructive pulmonary disease.

Authors:  Masaru Hasegawa; Yasuyuki Nasuhara; Yuya Onodera; Hironi Makita; Katsura Nagai; Satoshi Fuke; Yoko Ito; Tomoko Betsuyaku; Masaharu Nishimura
Journal:  Am J Respir Crit Care Med       Date:  2006-03-23       Impact factor: 21.405

10.  Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease.

Authors:  Onno M Mets; Ewoud J Smit; Firdaus A A Mohamed Hoesein; Hester A Gietema; Reinoud P H Bokkers; Mohamed Attrach; Saskia van Amelsvoort-van de Vorst; Ernst Th Scholten; Constantinus F M Buckens; Matthijs Oudkerk; Jan-Willem J Lammers; Mathias Prokop; Pim A de Jong
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  9 in total

1.  Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.

Authors:  Y W Kim; J H Kim; S H Yoon; J H Lee; C-H Lee; C S Shin; Y S Park
Journal:  Osteoporos Int       Date:  2016-08-01       Impact factor: 4.507

2.  Visual assessment of early emphysema and interstitial abnormalities on CT is useful in lung cancer risk analysis.

Authors:  Mathilde M W Wille; Laura H Thomsen; Jens Petersen; Marleen de Bruijne; Asger Dirksen; Jesper H Pedersen; Saher B Shaker
Journal:  Eur Radiol       Date:  2015-05-09       Impact factor: 5.315

3.  Emphysema Progression at CT by Deep Learning Predicts Functional Impairment and Mortality: Results from the COPDGene Study.

Authors:  Andrea S Oh; David Baraghoshi; David A Lynch; Samuel Y Ash; James D Crapo; Stephen M Humphries
Journal:  Radiology       Date:  2022-05-17       Impact factor: 29.146

4.  Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening Trial.

Authors:  Mathilde M Winkler Wille; Sarah J van Riel; Zaigham Saghir; Asger Dirksen; Jesper Holst Pedersen; Colin Jacobs; Laura Hohwü Thomsen; Ernst Th Scholten; Lene T Skovgaard; Bram van Ginneken
Journal:  Eur Radiol       Date:  2015-03-13       Impact factor: 5.315

Review 5.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

6.  Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts.

Authors:  Samuel Y Ash; Raúl San José Estépar; Sean B Fain; Ruth Tal-Singer; Robert A Stockley; Lars H Nordenmark; Stephen Rennard; MeiLan K Han; Debora Merrill; Stephen M Humphries; Alejandro A Diaz; Stefanie E Mason; Farbod N Rahaghi; Carrie L Pistenmaa; Frank C Sciurba; Gonzalo Vegas-Sánchez-Ferrero; David A Lynch; George R Washko
Journal:  Radiology       Date:  2021-02-16       Impact factor: 11.105

7.  The effect of comorbidities on COPD assessment: a pilot study.

Authors:  Ulla Møller Weinreich; Lars Pilegaard Thomsen; Barbara Bielaska; Vania Helbo Jensen; Morten Vuust; Stephen Edward Rees
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-25

8.  Comparative analysis of pathophysiological parameters between emphysematous smokers and emphysematous patients with COPD.

Authors:  Shuang Bai; Rui Ye; Cuihong Wang; Pengbo Sun; Li Zhao
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

9.  Increased respiratory morbidity in individuals with interstitial lung abnormalities.

Authors:  Nils Hoyer; Laura H Thomsen; Mathilde M W Wille; Torgny Wilcke; Asger Dirksen; Jesper H Pedersen; Zaigham Saghir; Haseem Ashraf; Saher B Shaker
Journal:  BMC Pulm Med       Date:  2020-03-19       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.